Results 141 to 150 of about 9,301 (205)

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

, 2011
Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yingnian Shen, Ginger H. Tomberlin, H. Luke Carter, Timothy M Broderick, Sigethy Scott, Takahiro Seki, Masanori Kobayashi, Mark Underwood   +12 more
openalex   +1 more source

Expression of HIV from a 1-LTR circular DNA in the absence of integration. [PDF]

Retrovirology
Gurgo C, Fenizia C, McKinnon K, Hsia RC, Franchini G.   +4 more
europepmc   +1 more source

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

, 2011
Isabelle Malet, Marc Wirden, Slim Fourati, Daniele Armenia, Bernard Masquelier, Lavinia Fabeni, Sophie Sayon, Christine Katlama, Carlo Federico Perno, Vincent Cálvez, Anne‐Geneviève Marcelin, Francesca Ceccherini‐Silberstein   +11 more
openalex   +1 more source

Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. [PDF]

Pharmaceutics
Tracey H, Bate ST, Ford S, Patel P, Bloomer J, Patel A, Taskar KS.   +6 more
europepmc   +1 more source

Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report. [PDF]

Open Forum Infect Dis
van Kampen JJA, van Nood E, Mahmud R, Krullaars Z, Voskamp T, Voskamp M, Nijssen T, Voermans JJC, Charpentier C, Le Hingrat Q, van de Vijver DAMC, Gruters RA, Mesplède T.   +12 more
europepmc   +1 more source

Drug resistance and genetic transmission characteristics of HIV-1 CRF55_01B in people living with HIV/AIDS (PLWHA) in Henan Province, China. [PDF]

Retrovirology
Ma J, Liu J, Wei S, Hou M, Zhao Q, Huo Y.   +5 more
europepmc   +1 more source

Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial

, 2011
Lauriane Goldwirt, Joséphine Braun, Nathalie De Castro, Isabelle Charreau, Aurélie Barrail‐Tran, Constance Delaugerre, François Raffi, Caroline Lascoux‐Combe, J Aboulker, Anne‐Marie Taburet, Jean‐Michel Molina   +10 more
openalex   +1 more source

i-DENV: development of QSAR based regression models for predicting inhibitors targeting non-structural (NS) proteins of dengue virus. [PDF]

Front Pharmacol
Gautam S, Thakur A, Kumar M.
europepmc   +1 more source

Reply to comment on ‘pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients’

, 2011
Aurélie Barrail‐Tran, Yazdan Yazdanpanah, Lauriane Goldwirt, Geneviève Chêne, Céline Colin, Christophe Piketty, Diane Bollens, Christine Katlama, Diane Descamps, Jean‐Michel Molina, Catherine Fagard, Anne‐Marie Taburet   +11 more
openalex   +1 more source

Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study. [PDF]

BMC Infect Dis
Squillace N, Ricci ED, Orofino G, Forcina G, Albini L, Menzaghi B, De Socio GV, Piconi S, Maggi P, Madeddu G, Pellicanò GF, Sarchi E, Celesia BM, Lagi F, Salomoni E, Di Biagio A, Bonfanti P.   +16 more
europepmc   +1 more source